ADM, a global leader in human and animal nutrition and the world’s premier agricultural origination and processing company and Daniel leads the development of new ingredients that act as microbiome modulators. He develops new probiotic, prebiotic and postbiotic products, as well as the use of genomic approaches in the creation of precise nutrition. Daniel joined ADM in 2017 following their acquisition of his biotechnological company – Biopolis. He holds a PhD in Biology from the University of Valencia and several post-doctorates from the Agricultural University of Wageningen in the Netherlands.
Daniel will present Postbiotics, the new frontier in microbiome solutions and will be a panellist on the panel: Stargazing – What does the future of pro- and prebiotics look like?